paraoxon has been researched along with methoctramine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casida, JE; Honda, H; Tomizawa, M | 1 |
| Lenina, OA; Petrov, KA | 1 |
2 other study(ies) available for paraoxon and methoctramine
| Article | Year |
|---|---|
Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
Topics: Animals; Brain; Drosophila; Houseflies; Insecta; Muscarinic Agonists; Muscarinic Antagonists; Pirenzepine; Quinuclidinyl Benzilate; Receptors, Muscarinic; Tritium | 2007 |
Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.
Topics: Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterases; Diamines; Diaphragm; Disease Models, Animal; Mice; Muscarinic Antagonists; Muscle Contraction; Muscle Weakness; Paraoxon; Parasympatholytics; Pirenzepine; Protective Agents; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Signal Transduction; Synaptic Transmission; Treatment Outcome | 2022 |